EVALUATION OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST IN DIAGNOSIS OF PULMONARY TUBERCULOSIS.

World Health Organization. Global tuberculosis report  Geneva: WHO, 2014. http://apps.who.int/iris/bitstream/10665/137094/1/9789 241564809_eng.pdf?ua=1.

Hopewell PC, Pai M, Maher D, et al. International standards for tuberculosis care. Lancet Infect Dis 2006;6(11):710-25.

Getahun H, Harrington M, O’Brien R, et al. Diagnosis of smear negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007;369(9578):2042-9.

Moore DF, Guzman JA, Mikhail LT. Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis 2005;52(3):247-54.

Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006;6(3):423-32.

Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization, 2013. http://www.who.int/tb/laboratory/policy_statements/en/)

Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011;6(9):1067-82.

Central TB division (India). Revised National TB Control Programme. Technical and Operational Guidelines for Tuberculosis Control in India, 2016.

Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of Clinical Microbiology 2010;48(1):229-37.

Annual Status Report. Central TB Division. Official website of the Revised National TB Control Programme, Directorate General of Health Services, Ministry of Health & Family Welfare Government of India. 2015. http://www.tbcindia.org.

Central TB Division (India). Revised National Tuberculosis Control Programme. Training Course for Program Manager (Modules1-4). April, 2011.           

Dewan R, Anuradha S, Khanna A, et al. Role of cartridge-based nucleic acid amplification test (CBNAAT) for early diagnosis of pulmonary tuberculosis in HIV. JIACM 2015;16(2):114-7.

Sen T, Joshi SR, Udwadia ZF. Tuberculosis and diabetes mellitus: merging epidemics. J Assoc Physicians India 2009;57:399-404.

Central TB Division. Official website of the Revised National TB Control Programme, Directorate General of Health Services, Ministry of Health & Family Welfare Government of India. 2012. http://www.tbcindia.org.

Theron G, Peter J, van Zyl-Smit RV, et al. Evaluation of the Xpert MTB/RIF Assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011;184(1):132-40.            

Geleta DA, Megerssa YC, Gudeta AN, et al. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiology 2015;15:220.

Agrawal M, Bajaj A, Bhatia V, et al. Comparative study of gene Xpert with ZN stain and culture in samples of suspected pulmonary tuberculosis. Journal of Clinical and Diagnostic Research 2016;10(5):DC09-DC12.

Sharma SK, Kohli M, Yadav RN, et al. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS One 2015;10(10):e0141011.

Sowjanya DS, Behera G, Reddy VVR, et al. CBNAAT: a novel diagnostic tool for rapid and specific detection of Mycobacterium tuberculosis in pulmonary samples. International Journal of Health Research in Modern Integrated Medical Sciences 2014;1:28-31.

Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363(11):1005-15.

Van Rie A, Page-Shipp L, Scott L, et al. Xpert(®) MTB/RIF for point-of care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn 2010;10(7):937-46.

Carriquiry G, Otero L, Gonza´lez-Lagos E, et al. A diagnostic accuracy study of Xpert(®)MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLoS One 2012;7(9):e44626.

Vadwai V, Boehme C, Nabeta P, et al. Need to confirm isoniazid susceptible cases in Xpert MTB/RIF rifampicin susceptible cases. Indian J Med Res 2012;135(4):560-1.